Venture Life Group (VLG) Sets New 52-Week Low at $37.00
Venture Life Group PLC (LON:VLG)’s share price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as GBX 37 ($0.50) and last traded at GBX 40 ($0.54), with a volume of 11899 shares trading hands. The stock had previously closed at GBX 40 ($0.54).
VLG has been the topic of a number of recent research reports. Northland Securities reiterated a “buy” rating and set a GBX 94 ($1.26) price objective on shares of Venture Life Group in a research note on Tuesday, February 13th. Northland Capital Partners reiterated a “buy” rating and set a GBX 100 ($1.34) price objective on shares of Venture Life Group in a research note on Wednesday, May 9th.
The firm also recently disclosed a dividend, which will be paid on Friday, June 22nd. Stockholders of record on Thursday, May 24th will be paid a dividend of GBX 0.04 ($0.00) per share. The ex-dividend date is Thursday, May 24th. This represents a dividend yield of 0.09%.
About Venture Life Group
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, and dermo-cosmetics for the ageing population in the United Kingdom, Europe, and internationally. It operates through Brands, and Development and Manufacturing segments. The company offers Benecol, a cardiovascular product for lowering cholesterol in food supplement; and neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance mental alertness, cognitive function, and mental performance in ageing brain.
Receive News & Ratings for Venture Life Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venture Life Group and related companies with MarketBeat.com's FREE daily email newsletter.